We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$44.4B
AUM Growth
+$1.2B
Cap. Flow
+$3.32B
Cap. Flow %
7.48%
Top 10 Hldgs %
17.65%
Holding
2,641
New
312
Increased
1,037
Reduced
994
Closed
281

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$555M
2
LLY icon
Eli Lilly
LLY
+$536M
3
META icon
Meta Platforms (Facebook)
META
+$433M
4
PGR icon
Progressive
PGR
+$330M
5
LRCX icon
Lam Research
LRCX
+$294M

Sector Composition

Rank Sector Weight
1 Technology 25.86%
2 Healthcare 15.38%
3 Financials 14.3%
4 Consumer Discretionary 11.43%
5 Industrials 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMCI icon
2026
Treace Medical Concepts
TMCI
$262M
$270K ﹤0.01%
32,200
-15,700
-33% -$141K
CDXS icon
2027
Codexis
CDXS
$158M
$268K ﹤0.01%
99,500
-304,200
-75% -$1.18M
UAMY icon
2028
United States Antimony
UAMY
$728M
$268K ﹤0.01%
121,600
-108,100
-47% -$187K
SGC icon
2029
Superior Group of Companies
SGC
$199M
$267K ﹤0.01%
24,400
+5,500
+29% +$77.3K
BR icon
2030
Broadridge
BR
$18.4B
$267K ﹤0.01%
1,100
-500
-31% -$118K
BMI icon
2031
Badger Meter
BMI
$3.87B
$266K ﹤0.01%
1,400
-100
-7% -$20.9K
CABO icon
2032
Cable One
CABO
$237M
$266K ﹤0.01%
+1,000
New +$292K
NEWT icon
2033
NewtekOne
NEWT
$426M
$266K ﹤0.01%
+22,200
New +$281K
PRDO icon
2034
Perdoceo Education
PRDO
$2.17B
$264K ﹤0.01%
10,500
-6,500
-38% -$173K
HTT
2035
High Templar Tech Ltd
HTT
$370M
$264K ﹤0.01%
98,184
-9,900
-9% -$28K
AMRC icon
2036
Ameresco
AMRC
$980M
$263K ﹤0.01%
+21,800
New +$395K
AORT icon
2037
Artivion
AORT
$1.34B
$263K ﹤0.01%
+10,700
New +$297K
JBI icon
2038
Janus International
JBI
$702M
$263K ﹤0.01%
36,500
-44,800
-55% -$356K
SSTK icon
2039
Shutterstock
SSTK
$209M
$261K ﹤0.01%
14,000
-20,500
-59% -$525K
CVCO icon
2040
Cavco Industries
CVCO
$4.36B
$260K ﹤0.01%
500
-1,700
-77% -$855K
EVC icon
2041
Entravision Communication
EVC
$1.02B
$260K ﹤0.01%
123,700
-26,200
-17% -$57.3K
TLN
2042
Talen Energy Corp
TLN
$15.1B
$260K ﹤0.01%
1,300
-37,400
-97% -$8.11M
AZZ icon
2043
AZZ Inc
AZZ
$4.24B
$259K ﹤0.01%
3,100
-5,400
-64% -$482K
SEM
2044
DELISTED
Select Medical
SEM
$259K ﹤0.01%
+15,500
New +$285K
PFIS icon
2045
Peoples Financial Services
PFIS
$718M
$258K ﹤0.01%
+5,800
New +$283K
TBI
2046
Trueblue
TBI
$227M
$258K ﹤0.01%
48,500
-11,300
-19% -$77.2K
DXPE icon
2047
DXP Enterprises
DXPE
$2.3B
$257K ﹤0.01%
3,127
-900
-22% -$83K
NPCE icon
2048
Neuropace
NPCE
$465M
$257K ﹤0.01%
20,900
+10,400
+99% +$130K
HBM icon
2049
Hudbay
HBM
$9.76B
$256K ﹤0.01%
33,746
-749,400
-96% -$6.1M
AUTL
2050
Autolus Therapeutics
AUTL
$389M
$255K ﹤0.01%
164,700
-168,700
-51% -$342K

Similar funds

Two Sigma Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Two Sigma Advisers held 2,641 positions worth $44.4B, up 2.8% from $43.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Two Sigma Advisers deployed $3.32B of net new capital in Q1 2025, opening 312 new positions and adding to 1,037 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 553,800 shares worth $351M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $555M trimmed.

  • Two Sigma Advisers's largest Q1 2025 buy was Regeneron Pharmaceuticals: 553,800 shares worth $351M.
  • Two Sigma Advisers added most to Broadcom in Q1 2025, an estimated $519M increase.
  • Two Sigma Advisers's biggest Q1 2025 reduction was Visa, cutting an estimated $555M.
  • Two Sigma Advisers fully exited Abbott in Q1 2025, selling an estimated $158M.
  • Two Sigma Advisers's ten largest holdings make up 18% of its $44.4B portfolio in Q1 2025.
  • Two Sigma Advisers opened 312 new positions and closed 281 in Q1 2025.
  • Two Sigma Advisers's portfolio value rose 2.8% quarter-over-quarter to $44.4B.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.